Hesitancy to share vaccine IP will increase inequality
Over 100 nations back a waiver of IP rights for COVID-19 treatments, but a wealthy minority strongly oppose it
You must be signed in to read this analysis
In this article
- Industry response
- Government backing
- US support needed
- Potential backlash
- Compromise
What is this?
This article is from the Oxford Analytica Daily Brief, which analyses geopolitical, economic, social, business and industrial developments on a global and regional basis, providing clients with timely, authoritative analysis every business day of the year. Find out more about the Oxford Analytica Daily Brief, or request a trial.
